Stock Chart

PRGO

$14.32 +2.10%
Score: 32.9 AVOID NEW MONEY
LEAPs: SELL $10
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $10
Premium: $1.73
Expiry: Jan 15, 2027
Target: $8
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.25x (vs SPY: 0.4x | vs QQQ: 0.4x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
Bull Pennant weak / forming — below our quality gate quality 40/100
A Bull Pennant is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 70% of the time (n=1,684). Measured-move targets failed our backtest — none shown.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About PRGO - PERRIGO COMPANY PLC

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including …

Key Statistics

Market Cap $2B
Dividend Yield 0.08%

This PRGO stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track PRGO's price movements with trendlines, gamma walls, and key support/resistance levels.